Kaleido BioSciences

Last updated: July 29, 2024

Mike Bonney, CEO
Mike Bonney, CEO
USA | Funding: $230.9M (+)

Website: https://kaleido.com/

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.